Additional Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Monteregie Centre de Recherche
    Greenfield Park QC. J4V 2H1
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Ocala Lung & Critical Care
    Ocala FL. 34471
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    South Texas Veterans Health Care System - Audie L. Murphy VA Hospital
    San Antonio TX. 78229-4404
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    University of Michigan
    Ann Arbor MI. 48109-5000
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    St. Joseph's Healthcare Hamilton
    Hamilton ON. L8N 4A6
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Mercy St. Vincent Medical Center
    Toledo OH. 43608-2603
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Centre Hospitalier de l'Université de Montréal (CHUM)
    Montreal QC. H2X 0C1
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Baylor University Medical Center at Dallas
    Dallas TX. 75245-2017
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Stanford University School of Medicine
    Stanford CA. 94305
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    St. Paul's Hospital
    Vancouver BC. V6Z 1Y6
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    University of Washington Medical Center
    Seattle WA. 98195
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0493
    Royal Oak MI. 48073-6712
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0489
    Falls Church VA. 22042
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0478
    Trois-Rivieres QC. G9S4P3
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0487
    New York NY. 10027
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Synergy Respiratory & Cardiac Care
    Sherwood Park AB. T8H 0N2
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0192
    Milwaukee WI. 53226-3522
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Burlington Lung Clinic
    Burlington ON. L7N 3V2
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Lankenau Medical Center
    Wynnewood PA. 19096-3432
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0387
    New York NY. 10029
    View Details